Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Bharat Biotech to work on TB vaccine

    Bharat Biotech is in the process of bringing out a vaccine against tuberculosis and soon the firm will sign a MoU with another firm for technology.

    "Our honourable Prime Minister has got an agenda of 2025 for the eradication of tuberculosis. I think we are in that direction. But we don't have the technology so we are partnering with somebody else. On that matter we should be announcing soon," Krishna Ella, Chairman and Managing Director said in BioAsia 2022.

  • Online TABLT Pharmacy raised USD 1.5 million

    Kolkata-based TABLT Pharmacy has raised USD 1.5 million in pre-series A round from investors like JITO Angel Network, Tech Innovation, Lets Venture, Seeders Syndicate, Angel Bay and other angel investors. Also, the founders have themselves participated in this round.

    Tablt online pharmacy is launched in 2018 and it is dealing in medicines, OTCs and other healthcare products.

  • Repurposing FDA-approved drugs may help combat COVID-19

    Several FDA-approved drugs including for type 2 diabetes, hepatitis C and HIV significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. Specifically, the team found that these drugs inhibit certain viral enzymes, called proteases, that are essential for SARS-CoV-2 replication in infected human cells.

  • Biocon Biologics to Acquire Viatris Biosimilars Assets for up to USD 3.335 billion in Stock and Cash

    Biocon Biologics Ltd., a subsidiary of Biocon Ltd announced today that it has entered into a definitive agreement with its partner Viatris Inc.  . Accordingly, Biocon Biologics Ltd will acquire Viatris’ biosimilars business to create a unique fully integrated global biosimilars enterprise. Viatris will receive consideration of up to USD 3.335 billion, including cash up to USD 2.335 billion and Compulsorily Convertible Preference Shares  in BBL, valued at USD 1 billion.

  • Ministry of AYUSH collaborating with the Healthcare sector for Skill development said Vikram Singh, Director, Ministry of AYUSH

    PHD Chamber organized a technical session on Incentive and Schemes offered by Ministry of AYUSH, Govt. of India for ASU Sector on 24th February 2022 during AYUSH e-Mela.

  • Dr. Mahendrabhai Munjapara inaugurated the AYUSH eMela, Virtual Conference organized by PHDCCI

    PHD Chamber in collaboration with Ministry of AYUSH, Govt. of India is organizing AYUSH E-Mela Virtual Conference cum Expo 2021 from 24th-26th February 2022.

  • PCI mandate exit exam after diploma in pharmacy

    Pharmacy Council of India has mandated exit exam for D.Pharm candidates to register as pharmacist under section 12 of the Pharmacy Act, 1948. No person shall be registered as a Diploma in Pharmacy Exit Examination candidate unless he has passed Diploma in Pharmacy course from an institution approved by the PCI.

  • Indian made medicinal products illegally imported in Switzerland

    A large number of Indian made medicinal products illegally imported in Switzerland were seized by Swissmedic and the Federal Office for Customs and Border Security. These contained COVID-19 medicines like ivermectin, hydroxychloroquine or antibiotics and erectile stimulants from India.

    Swiss government agency along with customs had secured 9,421 packages containing illegally imported medicinal products during 2021. This is a significant increase on the previous year, when there were 6,733 such packages.

  • TRIPS waiver must be agreed for COVID-19, says MSF

    Medecins Sans Frontieres, International medical charity called on the European Union, the UK and Switzerland to swiftly adopt the landmark Waiver, which would lift intellectual property monopolies on COVID-19 medical tools, and is currently supported by more than 100 low and middle income countries. MSF also urged the US to show concrete leadership to accelerate the negotiations and to broaden the scope of its support beyond only vaccines to include medicines and diagnostics.

  • Experimental combinatorial therapy eliminates an incurable brain tumour

    A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy. This double treatment completely eliminated the tumour in the animal models used in the study. This study was carried out by researchers from the Institute of Biomedicine of Seville: Dr. Manuel Sarmiento Soto, Dr. Juan García Revilla, and Dr. José Luis Venero, in collaboration with Dr. Nabil Hajji and Dr. Nel Syed of Imperial College London.

Subscribe to Pharma News